DAT Antibodies

Santa Cruz Biotechnology features a diverse variety of DAT Antibodies, specifically targeting the dopamine transporter (DAT) protein. Monoclonal DAT antibodies enable precise detection in western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The dopamine transporter plays a crucial role in the regulation of dopamine levels in the brain, influencing neurotransmission and impacting various neurological functions. Abnormalities in DAT function are associated with several neuropsychiatric disorders, including attention deficit hyperactivity disorder (ADHD) and substance use disorders. Understanding DAT regulation and function provides critical insights into the development of therapeutic approaches for neurological conditions. DAT monoclonal antibodies support detailed analysis of dopamine signaling pathways and their role in neural communication. Investigating DAT expression patterns helps reveal mechanisms underlying neurotransmitter regulation and transport. Research utilizing DAT monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of neurological disorders and potential therapeutic interventions.